The Boards of Trustees/Directors of the PIMCO closed-end funds below (each, a "Fund" and, collectively, the "Funds") have declared a monthly distribution for each Fund's common shares as summarized below. For the following Funds, the distributions are payable on June 1, 2026 to shareholders of record on May 11, 2026, with an ex-dividend date of May 11, 2026: Monthly Distribution Per Share Fund NYSE Symbol Amount Change From Previous Month Percentage Change From Previous Month PIMCO Corporate & Income Strategy Fund (NYSE:PCN) $0.112500 - - PIMCO Corporate & Income Opportunity Fund (NYSE:PTY) $0.118800
Live Feed
Delayed 3mPress · Insider · FDA · Leadership Updates · Large Ownership Changes
Signed out · 3-min delay · Sign up for real-time
- PIMCO Closed-End Funds Declare Monthly Common Share Distributions
- SEC Form 4 filed by Director Ross Cathy D
4 - BALL Corp (0000009389) (Issuer)
- Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces Its Net Asset Value and Asset Coverage Ratios as of April 30, 2026
HOUSTON, May 01, 2026 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (the "Company") (NYSE:KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the "1940 Act") as of April 30, 2026. As of April 30, 2026, the Company's net assets were $2.8 billion, and its net asset value per share was $16.62. As of April 30, 2026, the Company's asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 676% and the Company's asset coverage ratio under the 1940 Act with respect to total leverage (debt and preferred sto
- Chief Executive Officer Hedberg Lars Johan converted options into 100,000 shares and covered exercise/tax liability with 39,350 shares (SEC Form 4) (withholding obligation)
4 - TANDY LEATHER FACTORY INC (0000909724) (Issuer)
- Director Penegor Todd Allan converted options into 3,369 shares, increasing direct ownership by 40% to 11,890 units (SEC Form 4)
4 - BALL Corp (0000009389) (Issuer)
- Lockheed Martin Awarded U.S. Space Force Space-Based Interceptor Contracts to Meet Layered Missile Defense Demand
HUNTSVILLE, Ala., May 1, 2026 /PRNewswire/ -- Lockheed Martin (NYSE: LMT) has been selected by U.S. Space Force Space Systems Command to develop capabilities supporting the Space-Based Interceptor (SBI) program. These agreements mark progress toward fielding core elements of an integrated, layered homeland defense solution. This work will accelerate development, testing and integration of SBI capabilities, delivering an early engagement layer that expands coverage, enhances survivability and strengthens deterrence against emerging missile threats.Lockheed Martin's SBI system le
- Director Panichella John E converted options into 1,833 shares (SEC Form 4)
4 - BALL Corp (0000009389) (Issuer)
- Officer Hecht Beth sold $103,805 worth of shares (16,667 units at $6.23) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 1,193,173 units (SEC Form 4)
4 - Xeris Biopharma Holdings, Inc. (0001867096) (Issuer)
- Chief Legal Officer Ring Christine sold $90,407 worth of shares (5,394 units at $16.76) as part of a pre-agreed trading plan, decreasing direct ownership by 17% to 26,453 units (SEC Form 4)
4 - Nurix Therapeutics, Inc. (0001549595) (Issuer)
- SEC Form 4 filed by Director Bryant John A
4 - BALL Corp (0000009389) (Issuer)
- New insider Balzer Thomas claimed ownership of 255,322 units of Common Stock; $0.0001 par value (SEC Form 3)
3 - Lakewood-Amedex Biotherapeutics Inc. (0002079272) (Issuer)
- Director Krognes Steve E. converted options into 154 shares, increasing direct ownership by 0.80% to 19,362 units (SEC Form 4)
4 - Guardant Health, Inc. (0001576280) (Issuer)
- New insider Cooper Kelvin claimed ownership of 300,594 units of Common Stock; $0.0001 par value (SEC Form 3)
3 - Lakewood-Amedex Biotherapeutics Inc. (0002079272) (Issuer)
- New insider Ceccacci Peter claimed ownership of 468,148 units of Common Stock; $0.0001 par value (SEC Form 3)
3 - Lakewood-Amedex Biotherapeutics Inc. (0002079272) (Issuer)
- DigitalBridge Prices $300 Million Financing Facility, to Repay Outstanding Series 2021-1 Notes
DigitalBridge Group, Inc. (NYSE:DBRG) (the "Company") today announced two of its subsidiaries, DigitalBridge Issuer, LLC and DigitalBridge Co-Issuer, LLC (together, the "Co-Issuers") have priced an offering of $300 million aggregate principal amount of Series 2026-1 6.326% Secured Fund Fee Revenue Notes, Class A-2 (the "Class A-2 Notes"). Interest payments on the Class A-2 Notes are payable on a quarterly basis. The anticipated repayment date of the Class A-2 Notes is June 2031. The Class A-2 Notes are expected to be issued by the Co-Issuers in a securitization transaction. The proceeds from the sale of the Class A-2 Notes, net of the payment of certain offering expenses and the deposits
- Large owner Wycoff W Kirk sold $912,514 worth of Class A Voting Common Stock (50,000 units at $18.25) (SEC Form 4)
4 - USCB FINANCIAL HOLDINGS, INC. (0001901637) (Issuer)